Loading clinical trials...

Investigator Initiated Trial to Evaluate Efficacy and Safety of LAENNEC (Human Placenta Hydrolysate) Administered by Ultrasonography Guided Subacromial Bursa Injection in Patients With Shoulder Impingement Syndrome | Clinical Trials | Clareo Health

COMPLETEDNA

Investigator Initiated Trial to Evaluate Efficacy and Safety of LAENNEC (Human Placenta Hydrolysate) Administered by Ultrasonography Guided Subacromial Bursa Injection in Patients With Shoulder Impingement Syndrome

A Randomized, Parallel-group, Placebo-controlled, Single-blind, Investigator Initiated Trial to Evaluate Efficacy and Safety of LAENNEC (Human Placenta Hydrolysate) Administered by Ultrasonography Guided Subacromial Bursa Injection in Patients With Shoulder Impingement Syndrome

NCT05528705•Green Cross Wellbeing

View on ClinicalTrials.gov

Summary

To patients with shoulder collision syndrome, LAENNEC (Human Placenta Hydrolysate) is administered as an injection in the ultrasonic induction underglone, to evaluate the effectiveness and safety.

Eligibility

Age

20 - 70 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. At the time of screening, 19 or 70 years
•2. Those who are suspected of rotator cuff lesions or damage due to shoulder pain
•3. Those who are judged to have a shoulder joint disease during screening
•4. Neer test, Hawkins-Kennedy inspection, job test, Painful Arc inspection or resisted showder external rotation test
•5. Those with a significant pain of 30 mm of Visual Analogue Scale (VAS)
•6. Those who can sign a test subject or to comply with the matters required for clinical trials.

Exclusion Criteria

•1. A person who appears in the movement of two or more shoulder joints with more than 50% of the joint movement limit on the passive shoulder joint operation scope test.
•2. Those who have confirmed the rupture of the entire layer by ultrasound
•3. Those with serious damage to the shoulders and the past power
•4. Those who have suspected fractures, dislocations, degenerative arthritis, and calcification in the shoulder radiation test in the shoulder radiation test.
•5. Those who complain of shoulder pain due to stroke, spinal cord injury, and other surgery
•6. Those with other shoulder diseases other than fifty dogs (rheumatoid arthritis, osteoarthritis, bone defect injuries, malignant tumors, etc.)
•7. Those who are accompanied by diseases of cervical spine or other upper limbs that have a significant effect on the shoulder
•8. Those who have performed steroid injections in the joint steel within 3 months of participation in clinical trials
•9. Those who have administered anti -inflammatory drugs within two weeks of participation in clinical trials
•10. Those with all other joint diseases that have musculoskeletal diseases that may affect effective evaluation, or that it is impossible to participate in this clinical trial.
+4 more criteria

Locations (3)

Keimyung University Dongsan Hospital

Daegu, South Korea

Chung-Ang University Gwangmyeong Hospital

Gwangmyeong, South Korea

Chung-Ang University Hospital

Seoul, South Korea

Key Dates

Start Date

September 13, 2022

Primary Completion Date

October 23, 2023

Completion Date

January 31, 2024

Last Updated

February 24, 2026

Enrollment

ACTUAL participants

Conditions

Shoulder Impingement Syndrome

Interventions

LAENNEC

BIOLOGICAL

0.9% normal saline

OTHER

The Effect of Lower Limb Kinetic Chain Exercise in Shoulder Impingement

NCT06195956

Shoulder Impingement Syndrome

View study

ENROLLING_BY_INVITATIONNA

Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions

NCT06435494

Shoulder DiseaseShoulder Impingement+7 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 24, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Investigator Initiated Trial to Evaluate Efficacy and Safety of LAENNEC (Human Placenta Hydrolysate) Administered by Ultrasonography Guided Subacromial Bursa Injection in Patients With Shoulder Impingement Syndrome

Inclusion Criteria

Exclusion Criteria

The Effect of Lower Limb Kinetic Chain Exercise in Shoulder Impingement

Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions

Effects of Kinetic Chain Exercises on Pain, Range of Motion and Disability in Shoulder Impingement Syndrome

Role of Dynamic Ultrasound in Assessment of Shoulder Impingement Syndrome

The Clinical Efficacy of Different Durations of Suprascapular Nerve Pulsed Radiofrequency

Can Shoulder Arthroscopy Work